First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes
| dc.contributor.author | Statsenko, G. | |
| dc.contributor.author | Schulz, C. | |
| dc.contributor.author | Chen, Y. | |
| dc.contributor.author | Paz-Ares, L. G. | |
| dc.contributor.author | Dvorkin, M. | |
| dc.contributor.author | Trukhin, D. | |
| dc.contributor.author | Reinmuth, N. | |
| dc.contributor.author | Garassino, M. C. | |
| dc.contributor.author | Voitko, O. | |
| dc.contributor.author | Hochmair, M. J. | |
| dc.contributor.author | ÖZGÜROĞLU, Mustafa | |
| dc.contributor.author | Verderame, F. | |
| dc.contributor.author | Havel, L. | |
| dc.contributor.author | Losonczy, G. | |
| dc.contributor.author | Conev, N. | |
| dc.contributor.author | Hotta, K. | |
| dc.contributor.author | Ji, J. H. | |
| dc.contributor.author | Broadhurst, H. | |
| dc.contributor.author | Byrne, N. | |
| dc.contributor.author | Thiyagarajah, P. | |
| dc.contributor.author | Goldman, J. W. | |
| dc.contributor.author | Alt, J. | |
| dc.date.accessioned | 2021-03-02T16:47:13Z | |
| dc.date.available | 2021-03-02T16:47:13Z | |
| dc.identifier.citation | Schulz C., Chen Y., Paz-Ares L. G. , Dvorkin M., Trukhin D., Reinmuth N., Garassino M. C. , Statsenko G., Voitko O., Hochmair M. J. , et al., "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes", ONCOLOGY RESEARCH AND TREATMENT, cilt.43, ss.144-145, 2020 | |
| dc.identifier.issn | 2296-5270 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_35c20886-b94e-4831-ad9e-511b1984fc86 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/3290 | |
| dc.language.iso | eng | |
| dc.subject | Onkoloji | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.title | First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes | |
| dc.type | Makale | |
| dc.relation.journal | ONCOLOGY RESEARCH AND TREATMENT | |
| dc.contributor.department | University of Regensburg , , | |
| dc.identifier.volume | 43 | |
| dc.identifier.startpage | 144 | |
| dc.identifier.endpage | 145 | |
| dc.contributor.firstauthorID | 2287966 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Makale [92796]
